Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
J Nutr Biochem ; 46: 90-99, 2017 08.
Article in English | MEDLINE | ID: mdl-28486173

ABSTRACT

Dietary fish oils have potential for prevention of colon cancer, and yet the mechanisms of action in normal and tumor colon tissues are not well defined. Here we evaluated the impact of the colonic fatty acid milieu on the formation of prostaglandins and other eicosanoids. Distal tumors in rats were chemically induced to model inflammatory colonic carcinogenesis. After 21 weeks of feeding with either a fish oil diet containing an eicosapentaenoic acid/ω-6 fatty acid ratio of 0.4 or a Western fat diet, the relationships between colon fatty acids and prostaglandin E2 (PGE2) concentrations were evaluated. PGE2 is a key proinflammatory mediator in the colon tightly linked with the initiation and progression of colon cancer. The fish oil vs. the Western fat diet resulted in reduced total fatty acid concentrations in serum but not in colon. In the colon, the effects of the fish oil on fatty acids differed in normal and tumor tissue. There were distinct lipodomic patterns consistent with a lipogenic phenotype in tumors. In tumor tissue, the eicosapentaenoic acid/arachidonic acid ratio, cyclooxygenase-2 expression and the mole percent of saturated fatty acids were significant predictors of inter-animal variability in colon PGE2 after accounting for diet. In normal tissues from either control rats or carcinogen-treated rats, only diet was a significant predictor of colon PGE2. These results show that the fatty acid milieu can modulate the efficacy of dietary fish oils for colon cancer prevention, and this could extend to other preventive agents that function by reducing inflammatory stress.


Subject(s)
Colon/metabolism , Colonic Neoplasms/diet therapy , Dinoprostone/metabolism , Eicosanoids/metabolism , Fish Oils/pharmacology , Animals , Body Weight , Colon/drug effects , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cyclooxygenase 2/metabolism , Dietary Supplements , Fatty Acids/metabolism , Lipid Metabolism , Male , Rats, Inbred F344
3.
Bone Rep ; 5: 141-149, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27350956

ABSTRACT

PURPOSE: Osteoporosis occurs in both women and men, but most of what we know about the condition comes from studies in females. The present study examined bone structure and function over an 18-month period in male C57BL/6 mice maintained on either a rodent chow diet (AIN76A) or a high-fat, Western-style diet (HFWD). Effects of mineral supplementation were assessed in both diets. METHODS: Trabecular and cortical bone structure in femora and vertebrae were assessed by micro-CT analysis. Following this, bone stiffness and strength measurements were made. Finally, bone levels of several cationic trace elements were quantified, and serum biomarkers of bone metabolism evaluated. RESULTS: Bone loss occurred over time in both diets but was more rapid and extensive in mice on the HFWD. Dietary mineral supplementation reduced bone loss in both diets and increased bone stiffness in the femora and bone stiffness and strength in the vertebrae. Bone content of strontium was increased in response to mineral supplementation in both diets. CONCLUSIONS: Bone loss was more severe in mice on the HFWD and mineral supplementation mitigated the effects of the HFWD. In comparison to previous findings with female C57BL/6 mice, the present studies indicate that males are more sensitive to diet and benefited from a healthy diet (AIN76A), while females lost as much bone on the healthy diet as on the HFWD. Male mice benefited from mineral supplementation, just as females did in the previous study.

4.
Biol Trace Elem Res ; 156(1-3): 210-20, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24096551

ABSTRACT

Progressive bone mineral loss and increasing bone fragility are hallmarks of osteoporosis. A combination of minerals isolated from the red marine algae, Lithothamnion sp. was examined for ability to inhibit bone mineral loss in female mice maintained on either a standard rodent chow (control) diet or a high-fat western diet (HFWD) for 5, 12, and 18 months. At each time point, femora were subjected to µ-CT analysis and biomechanical testing. A subset of caudal vertebrae was also analyzed. Following this, individual elements were assessed in bones. Serum levels of the 5b isoform of tartrate-resistant acid phosphatase (TRAP) and procollagen type I propeptide (P1NP) were also measured. Trabecular bone loss occurred in both diets (evident as early as 5 months). Cortical bone increased through month 5 and then declined. Cortical bone loss was primarily in mice on the HFWD. Inclusion of the minerals in the diet reduced bone mineral loss in both diets and improved bone strength. Bone mineral density was also enhanced by these minerals. Of several cationic minerals known to be important to bone health, only strontium was significantly increased in bone tissue from animals fed the mineral diets, but the increase was large (5-10 fold). Serum levels of TRAP were consistently higher in mice receiving the minerals, but levels of P1NP were not. These data suggest that trace minerals derived from marine red algae may be used to prevent progressive bone mineral loss in conjunction with calcium. Mineral supplementation could find use as part of an osteoporosis-prevention strategy.


Subject(s)
Bone Density/drug effects , Dietary Supplements , Minerals/pharmacology , Osteoporosis/diet therapy , Osteoporosis/metabolism , Rhodophyta/chemistry , Acid Phosphatase/metabolism , Animals , Female , Isoenzymes/metabolism , Mice , Minerals/chemistry , Osteoporosis/pathology , Peptide Fragments/metabolism , Procollagen/metabolism , Tartrate-Resistant Acid Phosphatase
5.
Biol Trace Elem Res ; 150(1-3): 467-76, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23008064

ABSTRACT

Gadolinium, a member of the lanthanoid family of transition metals, interacts with calcium-binding sites on proteins and other biological molecules. The overall goal of the present investigation was to determine if gadolinium could enhance calcium-induced epithelial cell growth inhibition in the colon. Gadolinium at concentrations as low as 1-5 µM combined with calcium inhibits proliferation of human colonic epithelial cells more effectively than calcium alone. Gadolinium had no detectable effect on calcium-induced differentiation in the same cells based on change in cell morphology, induction of E-cadherin synthesis, and translocation of E-cadherin from the cytosol to the cell surface. When the colon epithelial cells were treated with gadolinium and then exposed to increased calcium concentrations, movement of extracellular calcium into the cell was suppressed. In contrast, gadolinium treatment had no effect on ionomycin-induced release of stored intracellular calcium into the cytoplasm. Whether these in vitro observations can be translated into an approach for reducing abnormal proliferation in the colonic mucosa (including polyp formation) is not known. These results do, however, provide an explanation for our recent findings that a multi-mineral supplement containing all of the naturally occurring lanthanoid metals including gadolinium are more effective than calcium alone in preventing colon polyp formation in mice on a high-fat diet.


Subject(s)
Calcium Signaling/drug effects , Colon/drug effects , Gadolinium/pharmacology , Intestinal Mucosa/drug effects , Anticarcinogenic Agents/metabolism , Anticarcinogenic Agents/pharmacology , Cadherins/metabolism , Calcium Ionophores/pharmacology , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Cell Membrane/metabolism , Cell Proliferation/drug effects , Colon/cytology , Colonic Neoplasms/prevention & control , Contrast Media/metabolism , Contrast Media/pharmacology , Cytosol/drug effects , Cytosol/metabolism , Dietary Supplements , Gadolinium/metabolism , Gadolinium/therapeutic use , Gadolinium DTPA/metabolism , Gadolinium DTPA/pharmacology , Humans , Intestinal Mucosa/cytology , Osmolar Concentration , Protein Transport/drug effects
6.
Arch Dermatol Res ; 302(9): 669-77, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20607545

ABSTRACT

PADMA 28 is a multi-component herbal mixture formulated according to an ancient Tibetan recipe. PADMA 28 is known to stimulate collagen production and reduced levels of collagen-degrading matrix metalloproteinases (MMPs). The goal of the present study was to determine whether topical treatment of rat skin with PADMA 28 would improve skin structure/function, and whether subsequently induced abrasion wounds would heal more rapidly in skin that had been pretreated with PADMA 28. Hairless rats were exposed to a potent topical corticosteroid (Temovate) in combination with either DMSO alone or with PADMA 28 given topically. At the end of the treatment period, superficial wounds were created in the skin, and time to wound closure was assessed. Collagen production and matrix-degrading MMPs were assessed. Abrasion wounds in skin that had been pretreated with PADMA 28 healed more rapidly than did wounds in Temovate plus DMSO-treated skin. Under conditions in which improved wound healing was observed, there was an increased collagen production and decreased MMP expression, but no significant epidermal hyperplasia and no evidence of skin irritation. The ability to stimulate collagen production and inhibit collagen-degrading enzymes in skin and facilitate more rapid wound closure without irritation should provide a rationale for development of the herbal preparation as a "skin-repair" agent.


Subject(s)
Phytotherapy , Plant Extracts/administration & dosage , Skin/drug effects , Wounds, Penetrating/drug therapy , Wounds, Penetrating/physiopathology , Administration, Topical , Adrenal Cortex Hormones/administration & dosage , Animals , Disease Models, Animal , Humans , Male , Plant Preparations , Rats , Rats, Inbred Strains , Recovery of Function/drug effects , Skin/injuries , Skin/metabolism , Skin/pathology , Wound Healing/drug effects , Wounds, Penetrating/pathology
7.
Calcif Tissue Int ; 86(4): 313-24, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20180099

ABSTRACT

The purpose of this study was to determine whether a mineral-rich extract derived from the red marine algae Lithothamnion calcareum could be used as a dietary supplement for prevention of bone mineral loss. Sixty C57BL/6 mice were divided into three groups based on diet: the first group received a high-fat Western-style diet (HFWD), the second group was fed the same HFWD along with the mineral-rich extract included as a dietary supplement, and the third group was used as a control and was fed a low-fat rodent chow diet (AIN76A). Mice were maintained on the respective diets for 15 months. Then, long bones (femora and tibiae) from both males and females were analyzed by three-dimensional micro-computed tomography (micro-CT) and (bones from female mice) concomitantly assessed in bone strength studies. Tartrate-resistant acid phosphatase (TRAP), osteocalcin, and N-terminal peptide of type I procollagen (PINP) were assessed in plasma samples obtained from female mice at the time of sacrifice. To summarize, female mice on the HFWD had reduced bone mineralization and reduced bone strength relative to female mice on the low-fat chow diet. The bone defects in female mice on the HFWD were overcome in the presence of the mineral-rich supplement. In fact, female mice receiving the mineral-rich supplement in the HFWD had better bone structure/function than did female mice on the low-fat chow diet. Female mice on the mineral-supplemented HFWD had higher plasma levels of TRAP than mice of the other groups. There were no differences in the other two markers. Male mice showed little diet-specific differences by micro-CT.


Subject(s)
Bone Density Conservation Agents/pharmacology , Bone and Bones/drug effects , Cell Extracts/pharmacology , Diet , Rhodophyta/chemistry , Animal Feed , Animals , Bone and Bones/chemistry , Bone and Bones/physiology , Bone and Bones/ultrastructure , Cell Extracts/chemistry , Diet/veterinary , Dietary Fats/administration & dosage , Dietary Fats/pharmacology , Drug Evaluation, Preclinical , Female , Male , Mice , Mice, Inbred C57BL , Minerals/analysis , Osmolar Concentration , Western World , X-Ray Microtomography
8.
In Vitro Cell Dev Biol Anim ; 46(2): 114-22, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19915935

ABSTRACT

Normal and neoplastic human colon tissue obtained at surgery was used to establish conditions for organ culture. Optimal conditions included an atmosphere of 5% CO2 and 95% O2; tissue partially submerged with mucosa at the gas interface; and serum-free medium with 1.5 mM Ca2+ and a number of growth supplements. Histological, histochemical, and immunohistochemical features that distinguish normal and neoplastic tissue were preserved over a 2-d period. With normal tissue, this included the presence of elongated crypts with small, densely packed cells at the crypt base and mucin-containing goblet cells in the upper portion. Ki67 staining, for proliferating cells, was confined to the lower third of the crypt, while expression of extracellular calcium-sensing receptor was seen in the upper third and surface epithelium. E-cadherin and ß-catenin were expressed throughout the epithelium and confined to the cell surface. In tumor tissue, the same disorganized, abnormal glandular structures seen at time zero were present after 2 d. The majority of cells in these structures were mucin-poor, but occasional goblet cells were seen and mucin staining was present. Ki67 staining was seen throughout the abnormal epithelium and calcium-sensing receptor expression was weak and variable. E-cadherin was seen at the cell surface (similar to normal tissue), but in some places, there was diffuse cytoplasmic staining. Finally, intense cytoplasmic and nuclear ß-catenin staining was observed in cultured neoplastic tissue.


Subject(s)
Colon/pathology , Colonic Neoplasms/pathology , Organ Culture Techniques , Biomarkers/metabolism , Cadherins/metabolism , Carbon Dioxide/pharmacology , Cell Differentiation , Colon/growth & development , Eosine Yellowish-(YS)/metabolism , Hematoxylin/metabolism , Humans , Matrix Metalloproteinase 1/metabolism , Oxygen/pharmacology , Receptors, Calcium-Sensing/metabolism , beta Catenin/metabolism
9.
J Ethnopharmacol ; 103(3): 311-8, 2006 Feb 20.
Article in English | MEDLINE | ID: mdl-16221534

ABSTRACT

Pomegranate (Punica granatum) is an ancient fruit with exceptionally rich ethnomedical applications. The peel (pericarp) is well regarded for its astringent properties; the seeds for conferring invulnerability in combat and stimulating beauty and fertility. Here, aqueous fractions prepared from the fruit's peel and fermented juice and lipophilic fractions prepared from pomegranate seeds were examined for effects on human epidermal keratinocyte and human dermal fibroblast function. Pomegranate seed oil, but not aqueous extracts of fermented juice, peel or seed cake, was shown to stimulate keratinocyte proliferation in monolayer culture. In parallel, a mild thickening of the epidermis (without the loss of ordered differentiation) was observed in skin organ culture. The same pomegranate seed oil that stimulated keratinocyte proliferation was without effect on fibroblast function. In contrast, pomegranate peel extract (and to a lesser extent, both the fermented juice and seed cake extracts) stimulated type I procollagen synthesis and inhibited matrix metalloproteinase-1 (MMP-1; interstitial collagenase) production by dermal fibroblasts, but had no growth-supporting effect on keratinocytes. These results suggest heuristic potential of pomegranate fractions for facilitating skin repair in a polar manner, namely aqueous extracts (especially of pomegranate peel) promoting regeneration of dermis, and pomegranate seed oil promoting regeneration of epidermis.


Subject(s)
Cosmetics/pharmacology , Fibroblasts/drug effects , Keratinocytes/drug effects , Lythraceae , Matrix Metalloproteinase 1/metabolism , Plant Extracts/pharmacology , Procollagen/metabolism , Cell Proliferation , Cells, Cultured , Dose-Response Relationship, Drug , Fibroblasts/metabolism , Fruit , Humans , Hyperplasia , Keratinocytes/metabolism , Matrix Metalloproteinase Inhibitors , Organ Culture Techniques , Seeds , Skin/drug effects , Skin/pathology
10.
J Invest Dermatol ; 124(3): 524-9, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15737192

ABSTRACT

PADMA 28, a multi-component herbal mixture formulated according to an ancient Tibetan recipe, was assessed for effects on human dermal fibroblasts and epidermal keratinocytes in monolayer culture, and for effects on human skin in organ culture. PADMA 28 stimulated survival of fibroblasts in monolayer culture. In fibroblast monolayer culture and human skin organ culture, levels of matrix metalloproteinase-1 (MMP-1; interstitial collagenase) were reduced and type I procollagen production was increased. When keratinocytes were examined, there was no evidence of growth stimulation over a wide range of PADMA 28 concentrations. At high concentration, PADMA 28 inhibited keratinocyte proliferation. When organ cultures of human skin were treated with PADMA 28, there was no evidence of hyperplastic growth in the epidermis. Topical treatment of rhino mice with PADMA 28 failed to induce epidermal hyperplasia and was completely non-irritating. The ability to stimulate collagen production and inhibit the major collagen-degrading enzyme in skin without inducing a hyperplastic response in the epidermis may provide a basis for development of the herbal preparation as a "skin-repair" agent.


Subject(s)
Dermis/drug effects , Epidermis/drug effects , Herbal Medicine , Plant Extracts/pharmacology , Adolescent , Adult , Animals , Cell Division/drug effects , Dermis/cytology , Epidermal Cells , Fibroblasts/cytology , Fibroblasts/drug effects , Humans , Keratinocytes/cytology , Keratinocytes/drug effects , Mice , Mice, Hairless , Organ Culture Techniques , Retinoids/physiology
SELECTION OF CITATIONS
SEARCH DETAIL